シンポジウム

[S7] シンポジウム7「Vector Development」

2023年9月12日(火) 17:20 〜 18:50 第2会場 (10Ｆ 1009)

座長:岡田尚巳（東京大学医科学研究所遺伝子・細胞治療センター分子遺伝医学分野）,中井浩之（Oregon Health & Science University）

+全てマイスケジュールに登録

[S7-1] Promoting clinical translation of cardiac gene therapy

^○Kiyotake Ishikawa (Mount Sinai)

[S7-2] Development of Recombinant AAV for Human Gene Therapy: Vector Design and Manufacturing Strategies to Reduce Immune Responses

^○John Fraser Wright (Stanford University School of Medicine)

[S7-3] The safety and efficacy of pre-treatment with imlifidase prior to adeno associated virus (AAV)-based gene therapy in non-human primates with pre-existing anti-AAVrh74 antibodies

^○Rachael A Potter¹, Sohrab Khan¹, John Snedeker¹, Kaitlin Adegboye¹, Alex Haile¹, Behman Sayanjali¹, Nicole Pukos¹, Kyle Cochran¹, Jen Ahner¹, Ting Su¹, Nathalie Uzc?tegui², Yvonne Stenberg², Catja Freiburghaus², Lena Winstedt², Louise R Rodino-Klapac¹ (1.Sarepta Therapeutics, Inc., Cambridge, MA, USA, 2.Hansa Biopharma, Lund, Skane County, Sweden)